Friday This is a long interview that I began with the certainty that I would not be watching for more than about ten minutes. I became more and more hooked and ended up watching it right to the end. It is just over 1 1/2 hrs in length, but is well worth the time. … [Read more...]
Could a popular COVID-19 antiviral supercharge the pandemic?
Friday (Apologies for light posting this week; I'm busy doing other things) "A widely used COVID-19 drug may be driving the appearance of new SARS-CoV-2 variants, sparking concerns it could prolong and even reinvigorate the pandemic. The drug, molnupiravir, produced by Merck & Co., is designed to kill the virus by inducing mutations in the viral genome. A survey of … [Read more...]
When you know how to think it empowers you, far beyond those who only know what to think
Wednesday … [Read more...]
Russia, China and Gold
Sunday If the translation and interpretation are correct, then this is BIG news. Russia’s intentions are clarifying Jan 26, 2023·Alasdair Macleod We have confirmation from the highest sources that Russia and the Shanghai Cooperation Organisation (SCO) are considering using gold for pan-Asian trade settlements, fully replacing dollars and euros. In an article … [Read more...]
Kunstler on Ukraine
Saturday We are losing this unnecessary proxy war about as steadily as possible, and actually making Russia look good in the process. Russia could have ended the war in five minutes by turning Kiev into an ashtray, but it spent the first eight months of the operation trying to avoid busting up Ukraine’s infrastructure, so as not to turn it into a failed state (that would … [Read more...]